Homepage
Full 18-step deep-dive · ~20–30 min · a member feature.
No report run on this ticker yet
Only preliminary foundational data below
Sign in to run a fresh report
Free · results in ~10 min
For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for The Ensign Group, Inc. (ENSG) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Healthcare · Medical Care Facilities
San Juan Capistrano, CA 92675, United States
ensigngroup.net
Price
$182.97
Market Cap
$10.7B
Employees
46,000
Beta
0.69
Avg Volume
761,933
Last Dividend
$0.26
CEO
Mr. Barry R. Port
The Ensign Group, Inc. is a healthcare services holding company that operates through a network of independent subsidiaries across the United States. The company focuses on post-acute care, providing skilled nursing, senior living, and rehabilitative services, including physical, occupational, and speech therapies, as well as various other healthcare and ancillary services. Its operations are organized primarily into skilled services and a real estate segment, with facilities offering short-term transitional care, long-term nursing care, and assisted living options in multiple states. In addition to clinical care, The Ensign Group, Inc. invests in, owns, and leases healthcare real estate used by its operating subsidiaries, supporting the post-acute care continuum. Ancillary businesses include mobile diagnostics, medical transportation, long-term care pharmacy, and consulting services, which complement its core facility-based operations. Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group, Inc. plays a significant role in the U.S. post-acute and senior care market by combining healthcare operations with strategic real estate ownership and services infrastructure.
Runs with full report
Earnings Schedule
Checked daily · calendar updated Aug 8 No upcoming print on the calendar yet — companies typically confirm a few weeks ahead. Last print was Jul 27, 2026.
EPS surprise history — vs analyst consensus · 4 prints of vendor history
+2.9%
May '26
+6.2%
May '26
-14.3%
Jun '26
+3.8%
Jul '26
| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Jul 27, 2026 | $1.85 | $1.92 +3.8% | — | — |
| Jun 25, 2026 | $-0.14 | $-0.16 -14.3% | — | — |
| May 20, 2026 | $2.91 | $3.09 +6.2% | — | — |
| May 12, 2026 | $0.68 | $0.70 +2.9% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Recent SEC Filings
| Filed | Form | Document |
|---|---|---|
| Jul 31, 2026 | SCHEDULE 13G/A | View |
| Jul 29, 2026 | 4 | View |
| Jul 28, 2026 | SCHEDULE 13G/A | View |
| Jul 27, 2026 | 144 | View |
| Jul 27, 2026 | 8-K | View |
| Jul 27, 2026 | 10-Q | View |
| Jul 22, 2026 | 4 | View |
| Jul 20, 2026 | 144 | View |
| Jul 17, 2026 | 4 | View |
| Jul 17, 2026 | 4 | View |
| Jul 17, 2026 | 4 | View |
| Jul 17, 2026 | 4 | View |
Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.
Price Overview
Last updated: Aug 9, 2026 3:54am (just now)
Current data · timestamped when a report runs
$182.97
Change · Aug 9
+1.31 (+0.72%)
Day Range
$180.95 – $183.28
52-Week Range
$141.58 – $218.00
50-Day MA
$166.97
200-Day MA
$182.78
Volume
294,200.00
Share Structure
Outstanding
58,272,000.00
Float
55,681,276.00
Free Float
95.6%
High free float
— 95.6% of shares trade freely, ~4.4% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
TD Twelve Data statement
HEX SEC filing
P/E Ratio (Price per dollar of earnings)
HEXStock Price / EPS (Diluted)
31.33
Stock Price: $182.97
EPS (Diluted): 5.84
EPS (Diluted): 5.84
P/B Ratio (Price vs net asset value)
HEXStock Price / Book Value Per Share
4.82
Stock Price: $182.97
Total Equity: $2.23B
Shares: 58,873,000
Total Equity: $2.23B
Shares: 58,873,000
EV/EBITDA (Total value vs operating profit)
HEXEnterprise Value / EBITDA
19.34
Market Cap: $10.66B
Total Debt: $141.76M
Cash: $503.88M
EBITDA: $529.63M
Total Debt: $141.76M
Cash: $503.88M
EBITDA: $529.63M
Enterprise Value (Takeover price (cap + debt - cash))
HEXMarket Cap + Total Debt - Cash
$10.2B
Market Cap: $10.66B
Total Debt: $141.76M
Cash: $503.88M
Total Debt: $141.76M
Cash: $503.88M
Gross Margin (Revenue left after direct costs)
HEXGross Profit / Revenue
20.5%
Gross Profit: $1.04B
Revenue: $5.06B
Revenue: $5.06B
Operating Margin (Revenue left after all operations)
HEXOperating Income / Revenue
8.4%
Operating Income: $425.31M
Revenue: $5.06B
Revenue: $5.06B
Net Margin (Revenue left as actual profit)
HEXNet Income / Revenue
6.8%
Net Income: $343.97M
Revenue: $5.06B
Revenue: $5.06B
ROE (Profit from shareholder equity)
HEXNet Income / Total Equity
15.4%
Net Income: $343.97M
Total Equity: $2.23B
Total Equity: $2.23B
ROIC (Profit from all invested capital)
HEXNOPAT / Invested Capital
17.2%
Operating Income: $425.31M
Tax Rate: 24.4%
Equity: $2.23B
Total Debt: $141.76M
Cash: $503.88M
Tax Rate: 24.4%
Equity: $2.23B
Total Debt: $141.76M
Cash: $503.88M
Current Ratio (Can it pay short-term bills)
HEXCurrent Assets / Current Liabilities
1.42
Current Assets: $1.27B
Current Liabilities: $894.35M
Current Liabilities: $894.35M
Debt/Equity (Leverage — debt vs equity)
HEXTotal Debt / Total Equity
0.06
Short-Term Debt: $4.23M
Long-Term Debt: $137.53M
Total Debt: $141.76M
Total Equity: $2.23B
Long-Term Debt: $137.53M
Total Debt: $141.76M
Total Equity: $2.23B
Rev/Share (Top-line per share)
HEXRevenue / Shares Outstanding
$85.91
Revenue: $5.06B
Shares: 58,873,000
Shares: 58,873,000
Book Value/Share (Net assets per share)
HEX(Total Assets - Total Liabilities) / Shares
$37.96
Total Equity: $2.23B
Shares: 58,873,000
Shares: 58,873,000
FCF/Share (Real cash generated per share)
HEX(Operating Cash Flow + CapEx) / Shares
$9.58
Operating CF: $564.27M
CapEx: $0.00
Shares: 58,873,000
CapEx: $0.00
Shares: 58,873,000
Div Yield (Annual income from holding)
TDLast Annual Dividend / Stock Price
0.1%
Last Dividend: $0.26
Stock Price: $182.97
Stock Price: $182.97
Payout Ratio (Earnings paid out as dividends)
HEXDividends Paid / Net Income
4.2%
Dividends Paid: -$14.41M
Net Income: $343.97M
Net Income: $343.97M
Income Statement (Annual)
Last updated: Aug 9, 2026 3:54am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.6B | $3.0B | $3.7B | $4.3B | $5.1B |
| Cost of Revenue | $2.0B | $2.4B | $2.9B | $3.4B | $4.0B |
| Gross Profit | $607.6M | $671.0M | $788.1M | $883.6M | $1.0B |
| Operating Expenses | $347.1M | $374.2M | $532.8M | $525.3M | $613.5M |
| Operating Income | $260.5M | $296.8M | $255.4M | $358.3M | $425.3M |
| Net Income | $194.7M | $224.7M | $209.4M | $298.0M | $344.0M |
| EBITDA | $316.5M | $359.2M | $327.8M | $442.4M | $529.6M |
| EPS | $3.57 | $4.09 | $3.76 | $5.26 | $6.00 |
| EPS (Diluted) | $3.42 | $3.95 | $3.65 | $5.12 | $5.84 |
Balance Sheet (Annual)
Last updated: Aug 9, 2026 3:54am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $262.2M | $316.3M | $509.6M | $464.6M | $503.9M |
| Total Current Assets | $639.7M | $781.1M | $1.0B | $1.2B | $1.3B |
| Total Assets | $2.9B | $3.5B | $4.2B | $4.7B | $5.5B |
| Current Liabilities | $523.1M | $582.1M | $734.7M | $743.4M | $894.3M |
| Long-Term Debt | $152.9M | $149.3M | $145.5M | $141.6M | $137.5M |
| Total Liabilities | $1.8B | $2.2B | $2.7B | $2.8B | $3.2B |
| Total Equity | $1.0B | $1.2B | $1.5B | $1.8B | $2.2B |
| Retained Earnings | $734.0M | $946.3M | $1.1B | $1.4B | $1.8B |
Cash Flow (Annual)
Last updated: Aug 9, 2026 3:54am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $275.7M | $272.5M | $376.7M | $347.2M | $564.3M |
| Capital Expenditure | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Acquisitions (net) | -$6.0M | -$16.4M | $0 | — | — |
| Net Debt Issued / (Repaid) | $42.2M | -$3.7M | -$3.9M | -$4.0M | -$4.1M |
| Dividends Paid | -$11.5M | -$12.2M | -$12.9M | -$13.7M | -$14.4M |
| Stock Buybacks | -$10.1M | -$29.9M | $0 | $0 | -$20.0M |
| Net Change in Cash | $25.6M | $54.1M | $193.4M | -$45.0M | $39.3M |
Growth Trends (YoY %)
Last updated: Aug 9, 2026 3:54am (just now)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +15.1% | +23.3% | +14.2% | +18.7% |
| Gross Profit Growth | +10.4% | +17.4% | +12.1% | +17.6% |
| Operating Income Growth | +14.0% | -14.0% | +40.3% | +18.7% |
| Net Income Growth | +15.4% | -6.8% | +42.3% | +15.4% |
| EBITDA Growth | +13.5% | -8.7% | +35.0% | +19.7% |
Dividend History (Last 20)
Last updated: Aug 9, 2026 3:54am (just now)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-30 | $0.07 | — | — | — |
| 2026-03-31 | $0.07 | — | — | — |
| 2025-12-31 | $0.07 | — | — | — |
| 2025-09-30 | $0.06 | — | — | — |
| 2025-06-30 | $0.06 | — | — | — |
| 2025-03-31 | $0.06 | — | — | — |
| 2024-12-31 | $0.06 | — | — | — |
| 2024-09-30 | $0.06 | — | — | — |
| 2024-06-28 | $0.06 | — | — | — |
| 2024-03-27 | $0.06 | — | — | — |
| 2023-12-28 | $0.06 | — | — | — |
| 2023-09-28 | $0.06 | — | — | — |
| 2023-06-29 | $0.06 | — | — | — |
| 2023-03-30 | $0.06 | — | — | — |
| 2022-12-29 | $0.06 | — | — | — |
| 2022-09-29 | $0.06 | — | — | — |
| 2022-06-29 | $0.06 | — | — | — |
| 2022-03-30 | $0.06 | — | — | — |
| 2021-12-30 | $0.06 | — | — | — |
| 2021-09-29 | $0.05 | — | — | — |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-27 | Blouin Ann Scott | S-Sale | 175.00 | $181.88 | $31,829 |
| 2026-07-27 | Blouin Ann Scott | S-Sale | 200.00 | $185.00 | $37,000 |
| 2026-07-20 | Agwunobi John O | S-Sale | 392.00 | $171.06 | $67,056 |
| 2026-07-16 | Parkinson Mark Vincent | S-Sale | 100.00 | $168.12 | $16,812 |
| 2026-07-15 | SMITH BARRY M | A-Award | 600.00 | $0.00 | $0 |
| 2026-07-15 | Shaw Daren | A-Award | 600.00 | $0.00 | $0 |
| 2026-07-15 | Agwunobi John O | A-Award | 600.00 | $0.00 | $0 |
| 2026-07-15 | Abbott Swati Bargotra | A-Award | 600.00 | $0.00 | $0 |
| 2026-07-15 | Blouin Ann Scott | A-Award | 600.00 | $0.00 | $0 |
| 2026-07-15 | Parkinson Mark Vincent | A-Award | 600.00 | $0.00 | $0 |
Industry Benchmarks
Compares ENSG against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
Not applicable for this companies
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
Not applicable for this companies
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
Not applicable for this companies
4h
Dividend Discount Model
— For dividend/income stocks only
Not applicable for this companies
4i
Book Value Analysis
— For deep value / turnaround stocks only
Not applicable for this companies
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
Not applicable for this companies
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for ENSG — it's generated by the pipeline (
market-narrative step).
Claude Reading
No AI findings yet for ENSG — they're generated by the
pipeline (
ai-findings step) when a report is run on this ticker.
GPT Reading
No GPT reading yet for ENSG — it's generated by the
pipeline (
gpt-critique step) after the other Big-3 seats, when a
report is run on this ticker.
Grok Reading
No Grok reading yet for ENSG — it's generated by the
pipeline (
grok-critique step) alongside the other Big-3 seats, when a
report is run on this ticker.
Advanced Analysis Forensic deep-dive · three lenses
Character & Durability Scorecard
Ten long-horizon business-character traits the Quality / Value / Sentiment lenses don’t break out, scored 1–10.
No scorecard yet for ENSG — the ten traits are scored by the
pipeline (
ext-scorecard step) when a report is run on this ticker.
No community reviews yet for ENSG.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · twelvedata
v1.1.515 · 9f7cac68 · 2026-08-08 13:09:58